966 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
4 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
5 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
8 Not yet recruiting Prospective Observational Study To Identify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) And ALK Translocation And To Establish Their Therapeutic Management (IDEALK)
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Crizotinib
9 Not yet recruiting Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer
Conditions: Carcinoma, Small Cell;   Lung Neoplasms
Interventions: Radiation: high-dose TRT;   Radiation: standard-dose TRT
10 Recruiting Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer (TRINITY)
Condition: Small Cell Lung Cancer
Intervention: Drug: Rovalpituzumab tesirine
11 Not yet recruiting Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: durvalumab;   Biological: bavituximab
12 Not yet recruiting Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Dabrafenib;   Drug: Trametinib
13 Not yet recruiting LUME BioNIS: a Biomarker Study in Patients With NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention:
14 Recruiting Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
Condition: Carcinoma, Non-small Cell Lung
Interventions: Genetic: Genomic profile by FoundationOne;   Genetic: Genomic profile by other methods
15 Not yet recruiting MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Conditions: Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer;   Breast Cancer;   Cancer of Breast;   Cancer of the Breast;   Gastroesophageal Cancer;   Pancreatic Cancer;   Cancer of the Pancreas;   Colorectal Cancer;   Colorectal Carcinoma;   Renal Cancer;   Kidney Cancer;   Cancer of the Kidney;   Cancer of Kidney;   Ovarian Cancer;   Ovary Cancer;   Cancer of the Ovary;   Cancer of Ovary
Intervention: Drug: MEDI4736
16 Recruiting Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
Condition: Non Small Cell Lung Cancer
Interventions: Biological: chemotherapy followed dendritic cells;   Drug: pemetrexed and carboplatin
17 Not yet recruiting Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Docetaxel;   Drug: Nintedanib
18 Recruiting Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC
Condition: Non-Small Cell Lung Cancer(NSCLC)
Interventions: Drug: Paclitaxel Micelles for Injection;   Drug: Paclitaxel Injection;   Drug: Cisplatin
19 Not yet recruiting Exemestane in Post-Menopausal Women With NSCLC
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Exemestane
20 Recruiting National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Carcinoma, Squamous Cell;   Adenocarcinoma
Interventions: Drug: AZD4547;   Drug: AZD2014;   Drug: Palbociclib;   Drug: Crizotinib;   Drug: Selumetinib;   Drug: Docetaxel;   Drug: AZD5363;   Drug: AZD9291;   Drug: MEDI4736

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years